Zura Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Selling, General & Admin	34.39	33.16	30.79	18.64	3.79	1.91
Research & Development	58.36	42.08	24.4	44	25.84	45
Operating Expenses	92.75	75.25	55.19	62.64	29.63	46.91
Operating Income	-92.75	-75.25	-55.19	-62.64	-29.63	-46.91
Interest & Investment Income	6.04	6.34	8	3.58	0.01	-
Other Non Operating Income (Expenses)	0.89	0.26	-5.21	0.74	-0.2	-
EBT Excluding Unusual Items	-85.82	-68.65	-52.4	-58.32	-29.82	-46.91
Other Unusual Items	-	-	-	-2.24	-	-
Pretax Income	-85.82	-68.65	-52.4	-60.56	-29.82	-46.91
Earnings From Continuing Operations	-85.74	-68.65	-52.4	-60.56	-29.82	-46.91
Minority Interest in Earnings	-	-	-	0.2	1.74	-
Net Income	-85.74	-68.65	-52.4	-60.36	-28.08	-46.91
Preferred Dividends & Other Adjustments	30.7	30.7	-7.02	8.88	7.26	-
Net Income to Common	-116.45	-99.35	-45.39	-69.24	-35.33	-46.91
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	107	94	75	33	0	-
Shares Outstanding (Diluted)	107	94	75	33	0	-
Shares Change	17.17%	25.43%	127.05%	14392.36%	-	-
EPS (Basic)	-1.09	-1.06	-0.60	-2.09	-154.88	-
EPS (Diluted)	-1.09	-1.06	-0.60	-2.09	-154.88	-
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Free Cash Flow	-77.63	-64.93	-28.15	-15.05	-1.31	-1.68
Free Cash Flow Per Share	-0.72	-0.69	-0.38	-0.46	-5.75	-
EBITDA	-92.69	-75.2	-55.18	-	-	-
D&A For EBITDA	0.06	0.05	0.01	-	-	-
EBIT	-92.75	-75.25	-55.19	-62.64	-29.63	-46.91

SEC Filings: 10-K · 10-Q